Central administration of neuropeptide B, but not prolactin-releasing peptide, stimulates cortisol secretion in sheep. 2008

Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
Laboratory of Neurobiology, National Institute of Agrobiological Sciences, Tsukuba, Japan.

Two neuropeptides, neuropeptide B (NPB) and prolactin-releasing peptide (PrRP), have been suggested to play important roles in control of the hypothalamic-pituitary-adrenal (HPA) axis in rodents. The aim of the present study was to clarify the central actions of NPB or PrRP in sheep. Ovariectomized ewes were surgically implanted with a cannula directed to the lateral ventricle. They received intracerebroventricular (icv) administration of 400 mul of artificial cerebrospinal fluid, NPB (0.05, 0.5 or 5 nmol), PrRP (0.5, 5 or 50 nmol) or corticotropin-releasing hormone (CRH, 0.5 or 5 nmol) through the cannula, and blood samples were taken 30 and 0 min prior to and 15, 30, 60 and 90 min after the injection. Cortisol concentrations in plasma were determined by enzyme immunoassay. Administration of 0.5 nmol NPB resulted in a significant increase in the cortisol concentration compared with the vehicle control, whereas the cortisol concentration after lower or higher doses of NPB did not differ from the control value. Thus, an icv injection of NPB produced a bell-shaped dose-response of cortisol concentration. Administration of PrRP had no significant effect on the cortisol concentrations at any dose examined. Icv injection of CRH dose-dependently increased plasma cortisol concentrations. These results demonstrate that central NPB stimulates cortisol secretion, suggesting that this neuropeptide plays some roles in control of the HPA axis in sheep. On the other hand, unlike its role in rodents, PrRP is unlikely to be involved in control of the HPA axis in this species.

UI MeSH Term Description Entries
D007028 Hypothalamic Hormones Peptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation. Hypothalamic Pituitary-Regulating Hormones,Hypothalamic Pituitary-Regulating Peptides,Hormones, Hypothalamic,Hormones, Hypothalamic Pituitary-Regulating,Hypothalamic Pituitary Regulating Hormones,Hypothalamic Pituitary Regulating Peptides,Peptides, Hypothalamic Pituitary-Regulating,Pituitary-Regulating Hormones, Hypothalamic,Pituitary-Regulating Peptides, Hypothalamic
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
August 1991, Regulatory peptides,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
December 1999, Neuroscience letters,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
January 1990, The Journal of endocrinology,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
January 1996, Clinical endocrinology,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
October 2003, Neuroscience letters,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
October 2004, Journal of neuroendocrinology,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
May 2000, Neuroscience letters,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
February 2004, Physiology & behavior,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
January 1984, Psychoneuroendocrinology,
Kazutaka Mogi, and Shuichi Ito, and Shuichi Matsuyama, and Hiromi Ohara, and Ryosuke Sakumoto, and Kenichi Yayou, and Satoshi Ohkura, and Madoka Sutoh, and Yuji Mori, and Hiroaki Okamura
June 2023, Endocrinology,
Copied contents to your clipboard!